amdoxovir has been researched along with emtricitabine in 4 studies
| Studies (amdoxovir) | Trials (amdoxovir) | Recent Studies (post-2010) (amdoxovir) | Studies (emtricitabine) | Trials (emtricitabine) | Recent Studies (post-2010) (emtricitabine) |
|---|---|---|---|---|---|
| 33 | 5 | 2 | 1,706 | 464 | 1,329 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asif, G; Butler, SD; Chu, CK; Cote, PJ; George, AL; Gerin, JL; Hurwitz, SJ; Menne, S; Narayanasamy, J; Schinazi, RF; Tennant, BC | 1 |
| Jamard, C; Martin, P; Rimsky, L; Schorr, O; Seignères, B; Trépo, C; Werle, B; Zoulim, F | 1 |
| Almond, MR; Liotta, DC; Mao, S; Painter, GR | 1 |
| Otto, MJ | 1 |
2 review(s) available for amdoxovir and emtricitabine
| Article | Year |
|---|---|
Biochemical and mechanistic basis for the activity of nucleoside analogue inhibitors of HIV reverse transcriptase.
Topics: Adenine; Cytidine Triphosphate; Deoxycytidine; Deoxycytidine Monophosphate; Deoxyribonucleotides; Dioxolanes; DNA, Viral; Emtricitabine; HIV Infections; HIV Reverse Transcriptase; Humans; Kinetics; Molecular Structure; Nucleosides; Organophosphonates; Organophosphorus Compounds; Phosphorylation; Protein Binding; Protein Conformation; Purine Nucleosides; Reverse Transcriptase Inhibitors; Substrate Specificity; Tenofovir; Zalcitabine | 2004 |
New nucleoside reverse transcriptase inhibitors for the treatment of HIV infections.
Topics: Animals; Anti-HIV Agents; Clinical Trials as Topic; Cytidine Triphosphate; Deoxycytidine; Dideoxynucleosides; Dioxolanes; Emtricitabine; HIV Infections; Humans; Purine Nucleosides; Reverse Transcriptase Inhibitors; Thionucleosides; Zalcitabine | 2004 |
2 other study(ies) available for amdoxovir and emtricitabine
| Article | Year |
|---|---|
Antiviral effect of orally administered (-)-beta-D-2-aminopurine dioxolane in woodchucks with chronic woodchuck hepatitis virus infection.
Topics: Administration, Oral; Animals; Antiviral Agents; Dioxolanes; DNA, Viral; Dose-Response Relationship, Drug; Guanine; Half-Life; Hepatitis B Virus, Woodchuck; Hepatitis B, Chronic; Injections, Intravenous; Marmota; Prodrugs; Purines; Tissue Distribution | 2007 |
Effects of pyrimidine and purine analog combinations in the duck hepatitis B virus infection model.
Topics: Animals; Antiviral Agents; Arabinofuranosyluracil; Blotting, Southern; Cell Survival; Deoxycytidine; Dioxolanes; Disease Models, Animal; Drug Therapy, Combination; Ducks; Emtricitabine; Hepadnaviridae Infections; Hepatitis B Virus, Duck; Hepatitis B, Chronic; Hepatitis, Viral, Animal; Hepatocytes; Polymerase Chain Reaction; Purine Nucleosides; Reverse Transcriptase Inhibitors; Viral Load; Virus Replication | 2003 |